GlaxoSmithKline (GSK)

Anne Phillips Appointed VP of Novo Nordisk's Clinical Development, Medical and Regulatory Affairs for North America

Ribena Site: GSK May Face Industrial Action

Antitrust Probe in the EU Pharma Sector

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

Glaxo Close to Buying Chinese Drugmaker

Vaccine Deal Between GSK And Binnopharm in Russia

Penicillin: Dr. Reddy's Buys Glaxo's U.S. Business

Astra Tech: AstraZeneca Confirms Considering Spin-Off

Glaxo to Pay $750 Million in Adulterated Drugs Case

Topics • Chemistry

Live And Learn

Glaxosmithkline Says Roche's Herceptin Infringes Patents

Glaxosmithkline Hires Goldman Sachs Banker as new Chief Financial Officer

Lonza Signs Manufacturing Deal with Glaxosmithkline

Glaxosmithkline Head Says No Plan to Bid for Genzyme

EU Regulator Reviews Safety of Glaxosmithkline Swine Flu Jab

Novartis/Alcon Deal Cleared by EU Regulators

Sanofi Investors Oppose Big Hike In Genzyme Bid

Sanofi Shareholders Want Genzyme For About $19 Billion

White Knight Could Be Elusive For Genzyme

Genzyme Seen More Attractive To Sanofi Than Glaxo

Topics • Technology

Mobility for Simplicity

GSK Sells Italian Research Unit To Aptuit

Cutting Drug Prices Hampers New Development

German Drugs Gatekeeper Rejects GSK's Avandia Pill

Novo Pulls Drugs from Greece Over Price Cuts

South Africa Taps Patent Pool for Neglected Disease

Oracle Buying Drug Software Maker Phase Forward

Brenntag Gets Warm Reception On German Market Debut

Brenntag To Start Trading on Frankfurt Stock Exchange

Glaxo Seeks Out Japanese Partnerships

Pfizer, Glaxo Sign 10-year Vaccine Deal for Poor

Glaxo Nabs L'Oreal Exec To Head Consumer Health

China Drug List Seen Boosting Western Firms' Sales

Pandemic Has Not Yet Peaked, WHO Experts Advise

Glaxo Might Spin Off Italian Drug R&D

4 more articles

Top-Feature

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Interview

Stability in Motion

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Novartis International AG

Chemical Market Reporter

Thermo Fisher Scientific

Society of Chemical Industry (SCI)

Thomson Reuters

EDB Singapore

Sanofi S.A.

Cincinnati USA Reg. Chamber

Oracle Germany

Microinnova Engineering GmbH

Novo Nordisk A/S

ISPE D/A/CH e.V.

EvaluatePharma

GlaxoSmithKline (GSK) plc